Jefferies analyst Maury Raycroft lowered the price target on Kezer Life Sciences (NASDAQ: KZR) to $21.00 (from $27.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE